CERTAINTY : A CEllulaR immunoTherapy virtuAl twin for personalIsed cancer treatmeNT

(2023-2028) – For the European Health and Digital Executive Agency (HADEA) (European Commission) via Horizon Europe Programme (HORIZON-HLTH-2023-TOOL-05)

This project aims to create a multi-scale patient-specific human virtual twin for patients who are eligible for CAR T cell therapy, which can be extended to cellular immunotherapies in general. The virtual twin will support decision-making throughout the patient's journey, from diagnosis to pre-treatments, cellular immunotherapy, and late patient monitoring. This will enable patients and health experts to identify the most effective course of therapy. The CRIDS will be in charge of the proper management of personal data and will provide its expertise to ensure the project's compliance with the GDPR and other relevant legal instruments.

Researchers: Chloé Antoine et Manon Knockaert

Project n°:101136379

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them